Midwest Allergy Sinus Asthma is a clinical research site located in Normal, Illinois, United States 61761.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Midwest Allergy Sinus Asthma has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease.
Sponsors: Blueprint Medicines Corporation, Optinose US Inc., AnaptysBio, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Normal
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Midwest Allergy Sinus Asthma has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Midwest Allergy Sinus Asthma has 3 clinical trials on record, with 1 currently active. Their work covers Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease.
Midwest Allergy Sinus Asthma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.